Literature DB >> 33718236

Overexpression of ABCC1 Confers Drug Resistance to Betulin.

Xuan-Yu Chen1,2, Yuqi Yang2, Jing-Quan Wang2, Zhuo-Xun Wu2, Jing Li1, Zhe-Sheng Chen2.   

Abstract

Betulin is a lupane-type pentacyclic triterpene, which is isolated from birch bark. It has a broad spectrum of biological and pharmacological properties, such as anti-inflammatory, anti-tumor, anti-viral, and anti-bacterial activity. Herein, we explored the factors that may result in betulin resistance, especially with respect to its interaction with ATP-binding cassette subfamily C member 1 (ABCC1). ABCC1 is an important member of the ATP-binding cassette (ABC) transporter family, which is central to mediating multidrug resistance (MDR) in naturally derived anticancer agents. An MTT-based cell viability assay showed that ABCC1 overexpression has the ability to desensitize both cancer cell line and gene-transfected cell line to betulin and that this betulin-induced resistance can be antagonized by a known ABCC1 inhibitor MK571 at 25 μM. Additionally, betulin upregulates the ABCC1 protein expression level in both concentration-dependent and time-dependent manners, also blocks the transport function mediated by ABCC1. Subsequently, a high affinity score of betulin was achieved in a computational docking analysis, demonstrating a strong interaction of betulin with ABCC1.
Copyright © 2021 Chen, Yang, Wang, Wu, Li and Chen.

Entities:  

Keywords:  ATP-binding cassette sub-family C member 1 (ABCC1); betulin; multidrug resistance (MDR); multidrug resistance-associated protein 1 (MRP1); natural product

Year:  2021        PMID: 33718236      PMCID: PMC7951056          DOI: 10.3389/fonc.2021.640656

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  35 in total

1.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

Review 2.  ABC efflux pump-based resistance to chemotherapy drugs.

Authors:  Paul D W Eckford; Frances J Sharom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 3.  Post-translational modifications and chromatin dynamics.

Authors:  Thomas O Tolsma; Jeffrey C Hansen
Journal:  Essays Biochem       Date:  2019-04-23       Impact factor: 8.000

Review 4.  Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents.

Authors:  Sevgi Gezici; Nazım Şekeroğlu
Journal:  Anticancer Agents Med Chem       Date:  2019       Impact factor: 2.505

Review 5.  Post-transcriptional regulation of gene expression and human disease.

Authors:  Anita H Corbett
Journal:  Curr Opin Cell Biol       Date:  2018-03-06       Impact factor: 8.382

6.  Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.

Authors:  Xiuhua Zhao; Weiguo Wang; Yuangang Zu; Ying Zhang; Yong Li; Wei Sun; Chang Shan; Yunlong Ge
Journal:  Drug Deliv       Date:  2014-01-30       Impact factor: 6.419

7.  Completion of the canonical pathway for assembly of anticancer drugs vincristine/vinblastine in Catharanthus roseus.

Authors:  Yang Qu; Olga Safonova; Vincenzo De Luca
Journal:  Plant J       Date:  2018-11-10       Impact factor: 6.417

8.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

Authors:  S P Cole; G Bhardwaj; J H Gerlach; J E Mackie; C E Grant; K C Almquist; A J Stewart; E U Kurz; A M Duncan; R G Deeley
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

Review 9.  Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer.

Authors:  Nethaji Muniraj; Sumit Siddharth; Dipali Sharma
Journal:  Cancers (Basel)       Date:  2019-10-15       Impact factor: 6.639

10.  Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.

Authors:  R W Robey; Y Honjo; K Morisaki; T A Nadjem; S Runge; M Risbood; M S Poruchynsky; S E Bates
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more
  6 in total

1.  Editorial: Chemo-Radiation-Resistance in Cancer Therapy.

Authors:  Xiaoping Lin; Dexin Kong; Zhe-Sheng Chen
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

2.  MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study.

Authors:  Zhuo-Xun Wu; Qiu-Xu Teng; Yuqi Yang; Nikita Acharekar; Jing-Quan Wang; Min He; Sabesan Yoganathan; Jun Lin; Jian Wang; Zhe-Sheng Chen
Journal:  Acta Pharm Sin B       Date:  2021-12-30       Impact factor: 14.903

Review 3.  Drug resistance: from bacteria to cancer.

Authors:  Harsh Patel; Zhuo-Xun Wu; Yanglu Chen; Letao Bo; Zhe-Sheng Chen
Journal:  Mol Biomed       Date:  2021-09-10

4.  The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter.

Authors:  Han Fu; Zhuo-Xun Wu; Zi-Ning Lei; Qiu-Xu Teng; Yuqi Yang; Charles R Ashby; Yixiong Lei; Yuyin Lian; Zhe-Sheng Chen
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

5.  Chinese Medicine Formula Siwu-Yin Inhibits Esophageal Precancerous Lesions by Improving Intestinal Flora and Macrophage Polarization.

Authors:  Hui-Juan Shi; Xuan-Yu Chen; Xin-Ran Chen; Zhong-Bing Wu; Jian-Yong Li; Ya-Qin Sun; Dong-Xuan Shi; Jing Li
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

6.  SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib.

Authors:  Yan Chen; Rui Zhang; Dandan Mi; Qiuju Wang; Tingwenli Huang; Xinwei Dong; Hongwei Zhang; Hongtao Xiao; Sanjun Shi
Journal:  Gastric Cancer       Date:  2022-08-24       Impact factor: 7.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.